COMPARISON OF THE PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE-ACTIVITY IN HUMAN-TUMORS AND NORMAL-TISSUES

被引:7
作者
CHOONG, YS
LEE, SP
ALLEY, PA
机构
[1] UNIV AUCKLAND, SCH MED, DEPT MED, AUCKLAND, NEW ZEALAND
[2] UNIV AUCKLAND, SCH MED, DEPT SURG, AUCKLAND, NEW ZEALAND
来源
EXPERIMENTAL PATHOLOGY | 1988年 / 33卷 / 01期
关键词
D O I
10.1016/S0232-1513(88)80050-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:23 / 25
页数:3
相关论文
共 13 条
[1]  
ARMSTRONG RD, 1983, CANCER RES, V43, P2525
[2]  
ARMSTRONG RD, 1980, CANCER RES, V40, P3333
[3]   TUMOR INHIBITORY EFFECTS OF A NEW FLUOROURACIL DERIVATIVE - 5'-DEOXY-5-FLUOROURIDINE [J].
BOLLAG, W ;
HARTMANN, HR .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (04) :427-432
[4]   THE DEGRADATION OF 5'-DEOXY-5-FLUOROURIDINE BY PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE IN NORMAL AND CANCER TISSUES [J].
CHOONG, YS ;
LEE, SP .
CLINICA CHIMICA ACTA, 1985, 149 (2-3) :175-183
[5]   FLUORINATED PYRIMIDINES, A NEW CLASS OF TUMOUR-INHIBITORY COMPOUNDS [J].
HEIDELBERGER, C ;
CHAUDHURI, NK ;
DANNEBERG, P ;
MOOREN, D ;
GRIESBACH, L ;
DUSCHINSKY, R ;
SCHNITZER, RJ ;
PLEVEN, E ;
SCHEINER, J .
NATURE, 1957, 179 (4561) :663-666
[6]  
HOUGHTON JA, 1979, CANCER RES, V39, P2406
[7]  
ISHITSUKA H, 1980, GANN, V71, P112
[8]  
KONO A, 1983, CHEM PHARM BULL, V31, P175
[9]  
KRAMER MJ, 1979, P AM ASSOC CANC RES, V20, P79
[10]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265